IRIS
BONANNI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.899
EU - Europa 6.758
AS - Asia 2.490
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 16
AF - Africa 9
OC - Oceania 9
Totale 16.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.866
IT - Italia 1.666
IE - Irlanda 1.336
CN - Cina 1.308
UA - Ucraina 1.130
TR - Turchia 772
SE - Svezia 746
GB - Regno Unito 669
FR - Francia 487
DE - Germania 373
IN - India 289
FI - Finlandia 213
VN - Vietnam 34
RU - Federazione Russa 29
IR - Iran 26
JP - Giappone 25
CA - Canada 22
BE - Belgio 20
EU - Europa 19
NL - Olanda 15
SG - Singapore 12
MX - Messico 10
PL - Polonia 10
AT - Austria 9
CL - Cile 8
ES - Italia 8
CH - Svizzera 7
RO - Romania 7
DK - Danimarca 6
IL - Israele 6
NZ - Nuova Zelanda 6
HK - Hong Kong 5
NO - Norvegia 5
BR - Brasile 4
PK - Pakistan 4
PT - Portogallo 4
AU - Australia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GR - Grecia 3
KR - Corea 3
SC - Seychelles 3
SM - San Marino 3
BD - Bangladesh 2
BG - Bulgaria 2
BO - Bolivia 2
HU - Ungheria 2
LU - Lussemburgo 2
MA - Marocco 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
LV - Lettonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 16.201
Salva come PNG Salva come JPEG
Città #
Chandler 1.491
Jacksonville 1.342
Dublin 1.317
Princeton 621
Southend 570
Izmir 418
Nanjing 406
Ashburn 400
Dearborn 290
Wilmington 272
Cambridge 210
Altamura 195
Beijing 195
Chieti 182
Ann Arbor 144
Nanchang 139
New York 79
Woodbridge 75
Boardman 74
Rome 72
Hebei 69
Tianjin 67
Washington 66
Shenyang 61
Kunming 56
Milan 55
Grevenbroich 49
Pescara 45
Jiaxing 44
Norwalk 44
Changsha 41
Jinan 35
Dong Ket 34
Hangzhou 31
Houston 30
Seattle 30
Augusta 26
Falls Church 24
Capurso 23
Florence 23
Lanzhou 23
Leawood 22
Ardabil 21
Pune 21
Changchun 19
Hefei 19
Helsinki 19
Toronto 19
Brussels 18
Ningbo 17
San Mateo 17
Taizhou 15
Torino 15
London 14
Naples 14
Redwood City 13
Zhengzhou 13
L'aquila 12
Paris 12
Ufa 12
Cepagatti 11
Guangzhou 10
Chicago 9
Edinburgh 9
Catania 8
Lanciano 8
Monmouth Junction 8
Napoli 8
Shanghai 8
Teramo 8
Vasto 8
Amsterdam 7
Genova 7
Andover 6
Arezzo 6
Campobasso 6
Fairfield 6
Francavilla Al Mare 6
Frankfurt am Main 6
Mantova 6
Mexico City 6
Montesilvano 6
Mumbai 6
Orange 6
Spoltore 6
Brescia 5
Cagliari 5
Casaleone 5
Caserta 5
Hong Kong 5
Kocaeli 5
Kraków 5
Sassari 5
Singapore 5
Stockholm 5
Tappahannock 5
Agrigento 4
Ancona 4
Bangalore 4
Chiasso 4
Totale 9.932
Salva come PNG Salva come JPEG
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 291
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 267
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 214
Pre-trattamento antiematico per Test/terapia all'apomorfina 145
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 134
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 126
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 113
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 112
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 108
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 105
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 104
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 103
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 97
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 95
Progetto atrofia multisistemica: risultati preliminari. 89
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 88
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 84
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 84
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 83
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 83
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 82
Correlazione tra dinamica del repertorio TCR e reattività alla proteina basica della mielina (MBP) nel sangue periferico di pazienti con Sclerosi multipla esacerbante/remittente 81
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 81
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 81
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 81
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 81
Akinetic crisis in Dementia with Lewy Bodies 81
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 80
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 80
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 80
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 79
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 79
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 79
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 78
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 78
Paradoxical kinesia in parkinsonian patients surviving earthquake. 78
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 78
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 77
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 76
Instabilità posturale nel Parkinson non farmaco-responder 76
Decrease in a Leak Conductance Associated with Mitochondrial Complex V and Improved Bioenergetic Efficiency may Underlie Cytoprotection of at-Risk Neurons by Dexpramipexole 76
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 75
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 75
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 75
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 74
Pathological Gambling in PD is reduced by Amantadine 74
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 74
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study 74
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 73
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 73
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 73
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 73
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 72
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 72
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 72
Attention network in AD and DLB patients: a resting fMRI study. 72
Bipallidal lesions induce delayed and progressive parkinsonism 72
Brainstem evoked potentials and magnetic resonance imaging abnormalities in differential diagnosis of intracranial hypotension. 72
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 72
Valutazione mediante sistema di immagini virtuali VRRS 71
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 70
Valutazione dei potenziali evocati visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 70
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 70
Uso della amantadina nel trattamento delle discinesie e fluttuazioni motorie in pazienti affetti da Morbo di Parkinson 70
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 70
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 70
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 70
Post traumatic stress disorder heralding the onset of semantic frontotemporal dementia 70
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 69
Cohort study on tremor in DLB: prevalence and features 69
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 69
Mitochondrial Involvement in Neurodegenerative Dementia 69
Autoscopic phenomena: case report and review of literature. 68
Somatoform disorders in Parkinson’s Disease and Dementia with Lewy Bodies evidence underlying psychotic traits. 68
Atrofia Multisistemica: approccio diagnostico multidisciplinare 68
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 68
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 68
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms. 68
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 68
Shared T Cell Receptor Usage of Cerebrospinal Fluid Cells in Familial Multiple Sclerosis da: X° National A.I.N.I. Congress Association Italiana Neuroimmunologia - Florence, Italy, November 15/16,1999 67
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 67
Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine. 67
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. 67
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias 67
Cortical Network Topology in Prodromal and Mild Dementia Due to Alzheimer's Disease: Graph Theory Applied to Resting State EEG 67
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 67
New approaches to understanding hallucinations in Parkinson’s Disease: phenomenology and possible origins. 66
STUDIO DELLE COMPONENTI DI MEMBRANA DI UN PUTATIVO CANALE MITOCONDRIALE LEGATO ALLA MORTE CELLULARE IN UN MODELLO ANIMALE DI MALATTIA DI PARKINSON. 66
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 66
Serial analysis of peripheral blood T cell receptor (TCR) V beta repertoire by RT-PCR/SSCP in patients with multiple sclerosis (MS) and healthy controls. 66
Dynamics of peripheral blood T cell receptor V beta repertoire in patients with relapsing-remitting multiple sclerosis. 66
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 66
Improving diagnostic accuracy of DLB: An MRI study 66
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 66
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients 66
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up 66
An expert opinion on safinamide in Parkinson's disease 65
What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons 65
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 64
Regulation of Socs-1 and Gerp/TRIM-8 expression on multiple sclerosis patients undergoing interferon beta-1 treatment 64
Totale 8.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019607 0 0 0 0 0 0 0 0 0 29 22 556
2019/20203.080 928 207 25 80 260 212 398 300 109 218 315 28
2020/20211.751 268 23 276 61 110 324 44 53 132 207 154 99
2021/20221.366 33 20 62 158 77 45 46 117 121 53 198 436
2022/20234.307 353 597 289 438 382 841 278 297 546 60 109 117
2023/20242.019 175 71 169 95 148 655 499 131 37 39 0 0
Totale 17.084